Mechanism of action and potential therapeutic targets of ferroptosis suppressor protein 1 in liver diseases / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 1493-1497, 2024.
Article
em Zh
| WPRIM
| ID: wpr-1038669
Biblioteca responsável:
WPRO
ABSTRACT
Ferroptosis suppressor protein 1 (FSP1) is another major ferroptosis regulator besides glutathione peroxidase 4, which can scavenge intracellular reactive oxygen species and lipid peroxides and inhibit ferroptosis. In view of the key role of the liver in iron and lipid metabolism and its susceptibility to oxidative damage, more and more evidence has shown that FSP1 plays an important role in liver diseases such as metabolic associated fatty liver disease, hepatocellular carcinoma, acute liver failure, and alcoholic liver disease, and the related targets of FSP1 are expected to become a potential treatment option. This article comprehensively reviews FSP1, with a focus on the role of FSP1 in the pathophysiology of several common liver diseases and the potential of FSP1 as a target of liver diseases, in order to provide new ideas for the treatment of liver diseases.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Clinical Hepatology
Ano de publicação:
2024
Tipo de documento:
Article